Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / Common stock, par value $0.001 per share (the "Common Stock")
-
Shares outstanding
-
138,764,349
-
Total 13F shares
-
15,405,069
-
Share change
-
-8,742,739
-
Total reported value
-
$24,955,147
-
Put/Call ratio
-
152%
-
Price per share
-
$1.62
-
Number of holders
-
53
-
Value change
-
-$15,547,121
-
Number of buys
-
25
-
Number of sells
-
47
Institutional Holders of ARROWHEAD PHARMACEUTICALS, INC. - Common stock, par value $0.001 per share (the "Common Stock") (ARWR) as of Q2 2017
As of 30 Jun 2017 ARROWHEAD PHARMACEUTICALS, INC. - Common stock, par value $0.001 per share (the "Common Stock") (ARWR) had 53 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 15,405,069 shares of stock of the company.
Largest 10 holders included OppenheimerFunds, Inc., VANGUARD GROUP INC, BlackRock Inc., MILLENNIUM MANAGEMENT LLC, PERCEPTIVE ADVISORS LLC, GEODE CAPITAL MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, GOLDMAN SACHS GROUP INC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, and ELEMENT CAPITAL MANAGEMENT LLC.
This table shows 53 institutional shareholders of the security as of 30 Jun 2017.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.